OIC

Riverside Research Promotes Alka Bhave to Chief Operations Officer

Retrieved on: 
Monday, December 20, 2021
DEI, FAA, History of the University of Maryland, College Park, DHS, University, Leadership, Environment, Intelligence collection plan, National security, OIC, Software craftsmanship, College Park, Diversity, IC, Workforce, Efficiency, United States Department of Defense, Scaled agile framework, Innovation Center station, PMP, NASA, Program, Research, Industry, Commercial, Multimedia, View, PMI, Telecommunication, Electrical engineering, Management, Perspecta

WASHINGTON, Dec. 20, 2021 /PRNewswire/ --Riverside Research announces the promotion of Alka Bhave to Chief Operations Officer.In her new role, Ms. Bhave will oversee the company's corporate operations and drive transformation in services and capabilities.

Key Points: 
  • WASHINGTON, Dec. 20, 2021 /PRNewswire/ --Riverside Research announces the promotion of Alka Bhave to Chief Operations Officer.In her new role, Ms. Bhave will oversee the company's corporate operations and drive transformation in services and capabilities.
  • "I am thrilled to have Alka in this critical leadership role at Riverside Research," remarks Riverside Research CEO Dr. Steve Omick.
  • Ms. Bhave joined Riverside Research earlier this year as Vice President and Chief of Staff, and advanced to the role of Chief Operations Officer in December, highlighting her ability to implement strategies that support the organization's mission.
  • "I am honored to take on this expanded role to lead the company's operations in the best support of our programs, customers and their missions, further strengthening Riverside Research as a destination company," Ms. Bhave remarks.

Los Angeles Underserved Children Receive Visit From Santa at the Orthopaedic Institute for Children’s Annual “Toys & Joy” Celebration

Retrieved on: 
Thursday, December 9, 2021
Family, Philanthropy, Health, Consumer, Hospitals, Other Philanthropy, Children, University of Maryland Rehabilitation & Orthopaedic Institute, OIC, LAPD SWAT, Research, Health, Injury, Hospital, Family, Safety, Holiday, The Walt Disney Company, Coronavirus, CEO, Vaccination, UCLA Health, MD, Multimedia, COVID-19, Mask, LAPD, Amusement park

More than 800 children and family watched and shouted in anticipation as Santa Claus helicoptered in with the LAPD SWAT team to deliver holiday cheer and assorted presents at the Orthopaedic Institute for Childrens Toys & Joy annual celebration, held yesterday on OICs downtown Los Angeles campus.

Key Points: 
  • More than 800 children and family watched and shouted in anticipation as Santa Claus helicoptered in with the LAPD SWAT team to deliver holiday cheer and assorted presents at the Orthopaedic Institute for Childrens Toys & Joy annual celebration, held yesterday on OICs downtown Los Angeles campus.
  • In an event that has become a Los Angeles tradition, over the past 30 years OIC has brought holiday joy to approximately 25,000 underserved families throughout the community.
  • Orthopaedic Institute for Children was founded in 1911 as Los Angeles Orthopaedic Hospital and today is the largest pediatric orthopaedic facility on the West Coast focused solely on musculoskeletal conditions in children.
  • Our locations in downtown Los Angeles, Santa Monica, Westwood and Calexico treat the full spectrum of pediatric orthopaedic disorders and injuries.

RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans

Retrieved on: 
Wednesday, December 1, 2021
Patient, Clarithromycin, Ketoconazole, Anxiety, Diverticulitis, Brain, OIC, Nausea, Chills, Medicare, Multiple sclerosis, Cancer, Traffic barrier, PAMORA, Headache, GI, Flatulence, Alzheimer's disease, Abdominal pain, Chronic pain, Obstruction, Ischemic colitis, Nasdaq, Risk, Hyperhidrosis, Diarrhea, Adult, Irritability, Yawn, Methadone, Medicare Part D, Formulary, CYP3A4, Vomiting, TEL, Redhill, Opioid, Excipient, Diverticular disease, Bevacizumab, Analgesic, Epilepsy, Pharmaceutical industry

"This important new listing for Movantik, the market-leading PAMORA for opioid-induced constipation, as a preferred and unrestricted brand on a major National Medicare Part D formulary provides that access to more than 10 million more Americans covered by this formulary.

Key Points: 
  • "This important new listing for Movantik, the market-leading PAMORA for opioid-induced constipation, as a preferred and unrestricted brand on a major National Medicare Part D formulary provides that access to more than 10 million more Americans covered by this formulary.
  • Patients with known or suspected gastrointestinal (GI) obstruction and patients at risk of recurrent obstruction, due to the potential for GI perforation.
  • Patients with a known serious or severe hypersensitivity reaction to Movantik or any of its excipients.
  • Symptoms consistent with opioid withdrawal, including hyperhidrosis, chills, diarrhea, abdominal pain, anxiety, irritability, and yawning, occurred in patients treated with Movantik.

SES Foam, LLC Welcomes Edward F. Cassidy, Ph.D., as Chief Operating Officer

Retrieved on: 
Friday, November 19, 2021
Foam, CEO, OIC, Industry, Time, SES, Partnership, University, COO, Urethane, VP, History, University of Detroit Mercy, GLOBE, Cassidy, Imperial Chemical Industries, MSAS, Polymer science, Learning, NAFTA, SAC, Polyurethane, ICI, Association of Jesuit University Presses, Growth, Management

SPRING, Texas, Nov. 19, 2021 (GLOBE NEWSWIRE) -- SES Foam LLC is excited to announce Edward F. Cassidy, Ph.D., as our new Chief Operating Officer.

Key Points: 
  • SPRING, Texas, Nov. 19, 2021 (GLOBE NEWSWIRE) -- SES Foam LLC is excited to announce Edward F. Cassidy, Ph.D., as our new Chief Operating Officer.
  • Charles Valentine, who has served as COO and President for 12 years, will continue as President and CEO.
  • "Ed's addition to our already strong team is a true commitment by the SES board to support the growth of SES in the urethane industry,"said Charles Valentine.
  • We are confident that with Ed's support, SES will continue to lead the industry in spray foam technology."

Riverside Research's Commercial Innovation Center (CIC) and T-REX Innovation Center Announce Partnership

Retrieved on: 
Wednesday, November 17, 2021
Research, RF, MASINT, Government, Adoption, OIC, Technology, Industry, National security, Innovation Center station, T-REX, Partnership, Student, Washington Avenue, Doctor of Philosophy, National Geospatial-Intelligence Agency, CIC, EO, United States Department of Defense, Intelligence community, Nation, View, Commercial, DevOps, IR, NGA, Radar, Intelligence, Ecosystem, Multimedia, Intelligence collection plan, GEOINT, Online shopping, Renewable energy

WASHINGTON, Nov. 17, 2021 /PRNewswire/ -- Riverside Research's Commercial Innovation Center (CIC) and St. Louis, Missouri-based T-REX Innovation Center have formed a new partnership to further accelerate GEOINT, MASINT, and Multi-INT research and development.

Key Points: 
  • WASHINGTON, Nov. 17, 2021 /PRNewswire/ -- Riverside Research's Commercial Innovation Center (CIC) and St. Louis, Missouri-based T-REX Innovation Center have formed a new partnership to further accelerate GEOINT, MASINT, and Multi-INT research and development.
  • The new partnership will be a critical element of the T-REX Proving Grounds, a resource center dedicated to serving innovators, entrepreneurs, and researchers.
  • T-REX is a non-profit Innovation Acceleration Center dedicated to strengthening the economic vitality of St. Louis through its Geospatial Innovation Center, technology startup incubator, and its strategic initiatives to foster inclusive economic growth through technology innovation.
  • "We are so excited to establish this new partnership, said Mark Tatgenhorst, founding Director of the Geospatial Innovation Center at T-REX.

RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021

Retrieved on: 
Monday, October 25, 2021
Opioid, OIC, American College of Gastroenterology, TEL, Amoxicillin, ITT, Omeprazole, University, Helicobacter pylori, University of Tennessee Health Science Center, Guideline, Clarithromycin, History, CYP2C19, World Health Organization, FDA, World, FACG, PPI, Magnesium, Pivotal, Prescription, AGAF, Clinical trial, Chronic pain, Feinberg School of Medicine, WHO, American College, Nasdaq, Associate, Rifabutin, ACG, Physician, Pharmaceutical industry

TEL AVIV, Israel and RALEIGH, N.C., Oct. 25, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the presentation of four new analyses of Phase 3 Talicia (omeprazole magnesium, amoxicillin and rifabutin)[1] and Movantik (naloxegol)[2] data at the ACG 2021 Annual Scientific Meeting, taking place October 22-27, 2021.

Key Points: 
  • TEL AVIV, Israel and RALEIGH, N.C., Oct. 25, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the presentation of four new analyses of Phase 3 Talicia (omeprazole magnesium, amoxicillin and rifabutin)[1] and Movantik (naloxegol)[2] data at the ACG 2021 Annual Scientific Meeting, taking place October 22-27, 2021.
  • The first Talicia analysis evaluated physician-directed therapy data, confirming high utilization of clarithromycin and low rates of H. pylori eradication.
  • The two Movantik posters analyzed data from patients experiencing extreme opioid-induced constipation (OIC) with severe symptoms.
  • RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases.

Global Halal Food Market (2021 to 2027) - by Product, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, October 8, 2021
Food, Beverage, Retail, Organisation of Islamic Cooperation, Dairy, Hygiene, CAGR, COVID-19, Animal, MILO, Blood, Islam, Standard Barrel Act For Fruits, Vegetables, and Dry Commodities, Industry, OIC, Pew Research Center, Meat, Development, Organization, Muslims, Food safety, Agriculture

According to the publisher, Global Halal Food Market will reach to US$ 1,729.80 Million by 2027.

Key Points: 
  • According to the publisher, Global Halal Food Market will reach to US$ 1,729.80 Million by 2027.
  • Global Halal Food Market segmented into Meat & Alternatives, Milk & Milk Products, Grain Products, Fruit & Vegetables, Others.
  • The global halal food market is anticipated to grow significantly over the forecast period, owing to the growing Muslim population and dramatically rising food demand and prices.
  • The global halal food market is very competitive, with several companies competing to be in the market.

AM Best Assigns Credit Ratings to Orion Indemnity Company

Retrieved on: 
Thursday, October 7, 2021
Insurance, Professional Services, Fullerton, Mercury General, Mercury, Credit, Industry, OIC, AM Best, News, Risk management, Data, AM, Insurance, ALL

AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent) to Orion Indemnity Company (OIC) (Fullerton, CA).

Key Points: 
  • AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent) to Orion Indemnity Company (OIC) (Fullerton, CA).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

Breakthrough Discovery Spearheaded by Nicholas Bernthal, M.D., Prevents Infections Related to Orthopedic Implants

Retrieved on: 
Wednesday, October 6, 2021
Biotechnology, General Health, Surgery, Health, Pharmaceutical, Biomedical engineering, UCLA, Animal, UCLA Health, Infection, Hospital, Injury, Duke University, Cancer, Surgeon, Patient, Health, David Geffen School of Medicine at UCLA, Bacteria, Life, HIV/AIDS, Amputation, Â, Human, Research, OIC, Blood, Los, Orthopedic surgery, Bone, Interim, Breast cancer, Department, Dentistry, Medical device

In those roles, he manages bone and soft tissue tumors in children and has witnessed firsthand the surgical implant infections that had become, for many, an unavoidable risk.

Key Points: 
  • In those roles, he manages bone and soft tissue tumors in children and has witnessed firsthand the surgical implant infections that had become, for many, an unavoidable risk.
  • Dr. Bernthal felt otherwise and 10 years ago began research into how to prevent such infections.
  • As Dr. Bernthal points out, many children being treated for bone cancer have large portions of bone removed, which then requires large megaprosthetic orthopedic implants.
  • Part of the challenge of treating these infections is that bacteria colonize the surface of the implants themselves.

Riverside Research to Unveil the Commercial Innovation Center

Retrieved on: 
Monday, October 4, 2021
MSI, Intelligence, Research, Intelligence collection plan, USGIF, EO, Software, Multimedia, Innovation Center station, MASINT, Radar, Environment, IR, CIC, GEOINT, DevOps, HSI, Commercial, United States Department of Defense, View, OIC, National security, RF, Ecosystem, Doctor of Philosophy, Industry, Online shopping, Mobile phone

WASHINGTON, Oct. 4, 2021 /PRNewswire/ -- Riverside Research will officially introduce its Commercial Innovation Center (CIC) to a wide audience of Government officials, commercial data providers, and application developers at the 2021 USGIF GEOINT Symposium in St Louis, Missouri, Oct. 5-8.

Key Points: 
  • WASHINGTON, Oct. 4, 2021 /PRNewswire/ -- Riverside Research will officially introduce its Commercial Innovation Center (CIC) to a wide audience of Government officials, commercial data providers, and application developers at the 2021 USGIF GEOINT Symposium in St Louis, Missouri, Oct. 5-8.
  • The CIC supports and enables industry, scientific, academic, and governmental R&D activities by facilitating access to commercial remote sensing data.
  • Ann Carbonell, PhD, CIC PM
    Riverside Research is a not-for-profit organization advancing scientific research in the interest of National Security.
  • Through the company's Open Innovation Center (OIC), it invests in multi-disciplinary research and development and encourages collaboration to accelerate innovation and advance science.